Wave Life Sciences Ltd. Ordinary Shares (WVE) News
Latest headlines that mention WVE, newest first · each headline opens the original publisher
- Last price
- $3.21
- Day change
- +0.94%
- Next earnings
- 2026-10-27 BMO
WVE headlines
latest coverageWVE-007 obesity candidate shows 16.5% visceral fat improvement in early trials.
WVE-007 obesity candidate shows 16.5% visceral fat improvement in early trials.
This clinical-stage biotech develops precision genetic medicines for neurological and hepatic disorders via its PRISM platform.
WVE news alerts
Get an alert by email or push when a new headline mentions WVE.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.